よむ、つかう、まなぶ。
【参考資料2】 (9 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_26881.html |
| 出典情報 | 厚生科学審議会 会感染症部会（第63回 8／1）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
•
Hammarlund E. et al. Multiple diagnostic techniques identify
previously vaccinated individuals with protective immunity against
monkeypox. Nat Med. 2005;11(9):1005-11.
•
Isidro j, et al.. Phylogenomic characterization and signs of
microevolution in the 2022 multi-country outbreak of monkeypox
virus. Nature medicine. June 2022.
https://www.nature.com/articles/s41591-022-01907-y.
•
Karem KL. et al. Monkeypox-induced immunity and failure of
childhood smallpox vaccination to provide complete protection. Clin
Vaccine Immunol. 2007;14(10):1318-27.
•
Kennedy JS. et al. Safety and immunogenicity of LC16m8, an
attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis.
2011;204(9):1395-402.
•
Lederman ER, et al. Progressive vaccinia: case description and
laboratory-guided therapy with vaccinia immune globulin, ST-246,
and CMX001. J Infect Dis. 2012;206(9):1372–1385.
•
Lindholm DA, et al. Preemptive tecovirimat use in an active duty
member presenting with acute myeloid leukemia after smallpox
vaccination. Clin Infect Dis. 2019;69:2205–2207.
•
Nextstain. Genomic epidemiology of monkeypox virus
https://nextstrain.org/monkeypox
•
Saito T,
et al. 2009. Clinical and Immunological Response to
Attenuated Tissue-Cultured Smallpox Vaccine LC16m8. JAMA: The
Journal of the American Medical Association 301 (10): 1025–33.
•
SIGA. SIGA receives approval from the FDA for intravenous (IV)
formulation of TPOXX® (tecovirimat).
2022. https://investor.siga.com/news-releases/news-releasedetails/siga-receives-approval-fda-intravenous-iv-formulation-tpoxxr.
•
UKHSA. Investigation into monkeypox outbreak in England: technical
briefing 1.
https://www.gov.uk/government/publications/monkeypox-outbreaktechnical-briefings/investigation-into-monkeypox-outbreak-inengland-technical-briefing-1.
•
US FDA. FDA approves the first drug with an indication for treatment of
smallpox. 2018. https://www.fda.gov/news-events/pressannouncements/fda-approves-first-drug-indication-treatment-smallpox.
©National Institute of Infectious Diseases, Tokyo, Japan, 2022.
9/10
Hammarlund E. et al. Multiple diagnostic techniques identify
previously vaccinated individuals with protective immunity against
monkeypox. Nat Med. 2005;11(9):1005-11.
•
Isidro j, et al.. Phylogenomic characterization and signs of
microevolution in the 2022 multi-country outbreak of monkeypox
virus. Nature medicine. June 2022.
https://www.nature.com/articles/s41591-022-01907-y.
•
Karem KL. et al. Monkeypox-induced immunity and failure of
childhood smallpox vaccination to provide complete protection. Clin
Vaccine Immunol. 2007;14(10):1318-27.
•
Kennedy JS. et al. Safety and immunogenicity of LC16m8, an
attenuated smallpox vaccine in vaccinia-naive adults. J Infect Dis.
2011;204(9):1395-402.
•
Lederman ER, et al. Progressive vaccinia: case description and
laboratory-guided therapy with vaccinia immune globulin, ST-246,
and CMX001. J Infect Dis. 2012;206(9):1372–1385.
•
Lindholm DA, et al. Preemptive tecovirimat use in an active duty
member presenting with acute myeloid leukemia after smallpox
vaccination. Clin Infect Dis. 2019;69:2205–2207.
•
Nextstain. Genomic epidemiology of monkeypox virus
https://nextstrain.org/monkeypox
•
Saito T,
et al. 2009. Clinical and Immunological Response to
Attenuated Tissue-Cultured Smallpox Vaccine LC16m8. JAMA: The
Journal of the American Medical Association 301 (10): 1025–33.
•
SIGA. SIGA receives approval from the FDA for intravenous (IV)
formulation of TPOXX® (tecovirimat).
2022. https://investor.siga.com/news-releases/news-releasedetails/siga-receives-approval-fda-intravenous-iv-formulation-tpoxxr.
•
UKHSA. Investigation into monkeypox outbreak in England: technical
briefing 1.
https://www.gov.uk/government/publications/monkeypox-outbreaktechnical-briefings/investigation-into-monkeypox-outbreak-inengland-technical-briefing-1.
•
US FDA. FDA approves the first drug with an indication for treatment of
smallpox. 2018. https://www.fda.gov/news-events/pressannouncements/fda-approves-first-drug-indication-treatment-smallpox.
©National Institute of Infectious Diseases, Tokyo, Japan, 2022.
9/10